Global Hereditary Angioedema Treatment Industry Research Report 2020, Forecast to 2025

August 2020 | 105 pages | ID: GBDD28C6366EEN
WKinformation

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The Hereditary Angioedema Treatment market was valued at US$ xx in 2019, prior to COVID-19. Whereas post-COVID-19 scenario, the market for Hereditary Angioedema Treatment is projected to grow from US$ xx million in 2020, and is projected to reach xx by 2025, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Hereditary Angioedema Treatment industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Hereditary Angioedema Treatment by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Hereditary Angioedema Treatment market are discussed.

The market is segmented by types:

• C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
• Selective Bradykinin B2 Receptor Antagonists (Firazyr)
• Kallikrein Inhibitors (Kalbitor, Takhzyro)
• Others (Conventional Drugs, Pipeline Drugs)

It can be also divided by applications:

• Hospital Pharmacies
• Retail Pharmacies
• Others (online pharmacies, mail pharmacies)

And this report covers the historical situation, present status and the future prospects of the global Hereditary Angioedema Treatment market for 2015-2025. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.

• CSL
• Ionis Pharmaceuticals
• Pharming Group
• KalVista Pharmaceuticals
• Shire plc (Takeda Pharmaceutical Company Limited)
• BioCryst Pharmaceuticals
• Attune Pharmaceuticals

Report Includes:

• xx data tables and xx additional tables
• An overview of global Hereditary Angioedema Treatment market
• An detailed key players analysis across regions
• Analyses of global market trends, with historical data, estimates for 2020 and projections of compound annual growth rates (CAGRs) through 2025
• Insights into regulatory and environmental developments
• Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Hereditary Angioedema Treatment market
• Profiles of major players in the industry, including%li% CSL, Ionis Pharmaceuticals, Pharming Group, KalVista Pharmaceuticals, Shire plc (Takeda Pharmaceutical Company Limited).....

Research Objectives

• To study and analyze the global Hereditary Angioedema Treatment consumption (value & volume) by key regions/countries, product type and application, history data from 2015 to 2019, and forecast to 2025.
• To understand the structure of Hereditary Angioedema Treatment market by identifying its various subsegments.
• Focuses on the key global Hereditary Angioedema Treatment manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
• To analyze the Hereditary Angioedema Treatment with respect to individual growth trends, future prospects, and their contribution to the total market.
• To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
• To project the consumption of Hereditary Angioedema Treatment submarkets, with respect to key regions (along with their respective key countries).
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
• To strategically profile the key players and comprehensively analyze their growth strategies.

Contents

Global Hereditary Angioedema Treatment Market Report 2020, Forecast to 2025

1 SCOPE OF THE STUDY

1.1 Hereditary Angioedema Treatment Introduction
1.2 Research Programs
1.3 Analysis of Macroeconomic Indicators
1.4 Years Considered
1.5 Methodology
1.6 Data Source
1.7 Research Objectives

2 HEREDITARY ANGIOEDEMA TREATMENT INDUSTRY OVERVIEW

2.1 Global Hereditary Angioedema Treatment Market Size (Million USD) Comparison by Regions (2020-2025)
  2.1.1 Hereditary Angioedema Treatment Global Import Market Analysis
  2.1.2 Hereditary Angioedema Treatment Global Export Market Analysis
  2.1.3 Hereditary Angioedema Treatment Global Main Region Market Analysis
2.2 Market Analysis by Type
  2.2.1 C1 Estearse Inhibitors (Plasma Products, Recombinant Products)
  2.2.2 Selective Bradykinin B2 Receptor Antagonists (Firazyr)
  2.2.3 Kallikrein Inhibitors (Kalbitor, Takhzyro)
  2.2.4 Others (Conventional Drugs, Pipeline Drugs)
2.3 Market Analysis by Application
  2.3.1 Hospital Pharmacies
  2.3.2 Retail Pharmacies
  2.3.3 Others (online pharmacies, mail pharmacies)
2.4 Global Hereditary Angioedema Treatment Revenue, Sales and Market Share by Manufacturer
  2.4.1 Global Hereditary Angioedema Treatment Sales and Market Share by Manufacturer (2018-2020)
  2.4.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Manufacturer (2018-2020)
  2.4.3 Global Hereditary Angioedema Treatment Industry Concentration Ratio (CR5 and HHI)
  2.4.4 Top 5 Hereditary Angioedema Treatment Manufacturer Market Share
  2.4.5 Top 10 Hereditary Angioedema Treatment Manufacturer Market Share
  2.4.6 Date of Key Manufacturers Enter into Hereditary Angioedema Treatment Market
  2.4.7 Key Manufacturers Hereditary Angioedema Treatment Product Offered
  2.4.8 Mergers & Acquisitions Planning
2.5 Hereditary Angioedema Treatment Historical Development Overview
2.6 Market Dynamics
  2.6.1 Market Opportunities
  2.6.2 Market Risk
  2.6.3 Market Driving Force
  2.6.4 Porter's Five Forces Analysis
2.7 Coronavirus Disease 2019 (Covid-19): Hereditary Angioedema Treatment Industry Impact
  2.7.1 How the Covid-19 is Affecting the Hereditary Angioedema Treatment Industry
  2.7.2 Hereditary Angioedema Treatment Business Impact Assessment - Covid-19
  2.7.3 Market Trends and Hereditary Angioedema Treatment Potential Opportunities in the COVID-19 Landscape
  2.7.4 Measures / Proposal against Covid-19

3 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS

3.1 Upstream Analysis
  3.1.1 Macro Analysis of Upstream Markets
  3.1.2 Key Players in Upstream Markets
  3.1.3 Upstream Market Trend Analysis
  3.1.4 Hereditary Angioedema Treatment Manufacturing Cost Analysis
3.2 Downstream Market Analysis
  3.2.1 Macro Analysis of Down Markets
  3.2.2 Key Players in Down Markets
  3.2.3 Downstream Market Trend Analysis
  3.2.4 Sales Channel, Distributors, Traders and Dealers

4 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT MARKET SIZE CATEGORIZED BY REGIONS (2015-2020)

4.1 Global Hereditary Angioedema Treatment Sales Market Share by Region
4.2 Global Hereditary Angioedema Treatment Revenue Market Share by Region (2015-2019)
4.3 Global Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.4 North America Hereditary Angioedema Treatment Market Size Detail
  4.4.1 North America Hereditary Angioedema Treatment Sales Growth Rate (2015-2020)
  4.4.2 North America Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.5 Europe Hereditary Angioedema Treatment Market Size Detail
  4.5.1 Europe Hereditary Angioedema Treatment Sales Growth Rate (2015-2020)
  4.5.2 Europe Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.6 Japan Hereditary Angioedema Treatment Market Size Detail
  4.6.1 Japan Hereditary Angioedema Treatment Sales Growth Rate (2015-2020)
  4.6.2 Japan Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2015-2020)
4.7 China Hereditary Angioedema Treatment Market Size Detail
  4.7.1 China Hereditary Angioedema Treatment Sales Growth Rate (2015-2020)
  4.7.2 China Hereditary Angioedema Treatment Sales, Revenue, Price and Gross Margin (2015-2020)

5 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT MARKET SEGMENT BY TYPE

5.1 Global Hereditary Angioedema Treatment Revenue, Sales and Market Share by Type (2015-2020)
  5.1.1 Global Hereditary Angioedema Treatment Sales and Market Share by Type (2015-2020)
  5.1.2 Global Hereditary Angioedema Treatment Revenue and Market Share by Type (2015-2020)
5.2 C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Sales Growth Rate and Price
  5.2.1 Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Sales Growth Rate (2015-2020)
  5.2.2 Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Price (2015-2020)
5.3 Selective Bradykinin B2 Receptor Antagonists (Firazyr) Sales Growth Rate and Price
  5.3.1 Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Sales Growth Rate (2015-2020)
  5.3.2 Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Price (2015-2020)
5.4 Kallikrein Inhibitors (Kalbitor, Takhzyro) Sales Growth Rate and Price
  5.4.1 Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Sales Growth Rate (2015-2020)
  5.4.2 Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Price (2015-2020)
5.5 Others (Conventional Drugs, Pipeline Drugs) Sales Growth Rate and Price
  5.5.1 Global Others (Conventional Drugs, Pipeline Drugs) Sales Growth Rate (2015-2020)
  5.5.2 Global Others (Conventional Drugs, Pipeline Drugs) Price (2015-2020)

6 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT MARKET SEGMENT BY APPLICATION

6.1 Global Hereditary Angioedema TreatmentSales Market Share by Application (2015-2020)
6.2 Hospital Pharmacies Sales Growth Rate (2015-2020)
6.3 Retail Pharmacies Sales Growth Rate (2015-2020)
6.4 Others (online pharmacies, mail pharmacies) Sales Growth Rate (2015-2020)

7 GLOBAL HEREDITARY ANGIOEDEMA TREATMENT MARKET FORECAST

7.1 Global Hereditary Angioedema Treatment Sales, Revenue Forecast
  7.1.1 Global Hereditary Angioedema Treatment Sales Growth Rate Forecast (2020-2025)
  7.1.2 Global Hereditary Angioedema Treatment Revenue and Growth Rate Forecast (2020-2025)
  7.1.3 Global Hereditary Angioedema Treatment Price and Trend Forecast (2020-2025)
7.2 Global Hereditary Angioedema Treatment Sales Forecast by Region (2020-2025)
  7.2.1 North America Hereditary Angioedema Treatment Sales, Revenue Forecast (2020-2025)
  7.2.2 Europe Hereditary Angioedema Treatment Sales, Revenue Forecast (2020-2025)
  7.2.3 Japan Hereditary Angioedema Treatment Production, Revenue Forecast (2020-2025)
  7.2.4 China Hereditary Angioedema Treatment Production, Revenue Forecast (2020-2025)

8 ANALYSIS OF HEREDITARY ANGIOEDEMA TREATMENT INDUSTRY KEY MANUFACTURERS

8.1 CSL
  8.1.1 Company Details
  8.1.2 Product Information
  8.1.3 CSL Hereditary Angioedema Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.1.4 Main Business Overview
  8.1.5 CSL News
8.2 Ionis Pharmaceuticals
  8.2.1 Company Details
  8.2.2 Product Information
  8.2.3 Ionis Pharmaceuticals Hereditary Angioedema Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.2.4 Main Business Overview
  8.2.5 Ionis Pharmaceuticals News
8.3 Pharming Group
  8.3.1 Company Details
  8.3.2 Product Information
  8.3.3 Pharming Group Hereditary Angioedema Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.3.4 Main Business Overview
  8.3.5 Pharming Group News
8.4 KalVista Pharmaceuticals
  8.4.1 Company Details
  8.4.2 Product Information
  8.4.3 KalVista Pharmaceuticals Hereditary Angioedema Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.4.4 Main Business Overview
  8.4.5 KalVista Pharmaceuticals News
8.5 Shire plc (Takeda Pharmaceutical Company Limited)
  8.5.1 Company Details
  8.5.2 Product Information
  8.5.3 Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.5.4 Main Business Overview
  8.5.5 Shire plc (Takeda Pharmaceutical Company Limited) News
8.6 BioCryst Pharmaceuticals
  8.6.1 Company Details
  8.6.2 Product Information
  8.6.3 BioCryst Pharmaceuticals Hereditary Angioedema Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.6.4 Main Business Overview
  8.6.5 BioCryst Pharmaceuticals News
8.7 Attune Pharmaceuticals
  8.7.1 Company Details
  8.7.2 Product Information
  8.7.3 Attune Pharmaceuticals Hereditary Angioedema Treatment Production, Price, Cost, Gross Margin, and Revenue (2018-2020)
  8.7.4 Main Business Overview
  8.7.5 Attune Pharmaceuticals News

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Hereditary Angioedema Treatment Picture
Figure Research Programs/Design for This Report
Figure Global Hereditary Angioedema Treatment Market by Regions (2019)
Table Global Market Hereditary Angioedema Treatment Comparison by Regions (M USD) 2019-2025
Table Global Hereditary Angioedema Treatment Sales Growth (CAGR) (2019-2025) by Type
Figure Global Sales Market Share of Hereditary Angioedema Treatment by Type in 2019
Figure C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Picture
Figure Selective Bradykinin B2 Receptor Antagonists (Firazyr) Picture
Figure Kallikrein Inhibitors (Kalbitor, Takhzyro) Picture
Figure Others (Conventional Drugs, Pipeline Drugs) Picture
Table Global Hereditary Angioedema Treatment Sales by Application (2019-2025)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Application in 2019
Figure Hospital Pharmacies Picture
Figure Retail Pharmacies Picture
Figure Others (online pharmacies, mail pharmacies) Picture
Table Global Hereditary Angioedema Treatment Sales by Manufacturer (2018-2020)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Manufacturer in 2019
Table Global Hereditary Angioedema Treatment Revenue by Manufacturer (2018-2020)
Figure Global Hereditary Angioedema Treatment Revenue Market Share by Manufacturer in 2019
Table Global Hereditary Angioedema Treatment Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Hereditary Angioedema Treatment Manufacturer (Revenue) Market Share in 2019
Figure Top 10 Hereditary Angioedema Treatment Manufacturer (Revenue) Market Share in 2019
Table Date of Key Manufacturers Enter into Hereditary Angioedema Treatment Market
Table Key Manufacturers Hereditary Angioedema Treatment Product Type
Table Mergers & Acquisitions Planning
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Hereditary Angioedema Treatment
Table Key Players of Upstream Markets
Figure Sales Channel
Table Global Hereditary Angioedema Treatment Sales (K Units) by Region (2015-2020)
Table Global Hereditary Angioedema Treatment Sales Market Share by Region (2015-2019)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Region (2015-2019)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Region in 2018
Table Global Hereditary Angioedema Treatment Revenue (Million US$) by Region (2015-2020)
Table Global Hereditary Angioedema Treatment Revenue Market Share by Region (2015-2020)
Figure Global Hereditary Angioedema Treatment Revenue Market Share by Region (2015-2020)
Figure Global Hereditary Angioedema Treatment Revenue Market Share by Region in 2019
Table Global Hereditary Angioedema Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure North America Hereditary Angioedema Treatment Sales (K Units) Growth Rate (2015-2020)
Table North America Hereditary Angioedema Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Europe Hereditary Angioedema Treatment Sales (K Units) Growth Rate (2015-2020)
Table Europe Hereditary Angioedema Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure Japan Hereditary Angioedema Treatment Sales (K Units) Growth Rate (2015-2020)
Table Japan Hereditary Angioedema Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Figure China Hereditary Angioedema Treatment Sales (K Units) Growth Rate (2015-2020)
Table China Hereditary Angioedema Treatment Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table Global Hereditary Angioedema Treatment Sales by Type (2015-2020)
Table Global Hereditary Angioedema Treatment Sales Market Share by Type (2015-2020)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Type in 2019
Table Global Hereditary Angioedema Treatment Revenue by Type (2015-2020)
Table Global Hereditary Angioedema Treatment Revenue Market Share by Type (2015-2020)
Figure Global Hereditary Angioedema Treatment Revenue Market Share by Type in 2019
Figure Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Sales Growth Rate (2015-2020)
Figure Global C1 Estearse Inhibitors (Plasma Products, Recombinant Products) Price (2015-2020)
Figure Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Sales Growth Rate (2015-2020)
Figure Global Selective Bradykinin B2 Receptor Antagonists (Firazyr) Price (2015-2020)
Figure Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Sales Growth Rate (2015-2020)
Figure Global Kallikrein Inhibitors (Kalbitor, Takhzyro) Price (2015-2020)
Figure Global Others (Conventional Drugs, Pipeline Drugs) Sales Growth Rate (2015-2020)
Figure Global Others (Conventional Drugs, Pipeline Drugs) Price (2015-2020)
Table Global Hereditary Angioedema Treatment Sales by Application (2015-2020)
Table Global Hereditary Angioedema Treatment Sales Market Share by Application (2015-2020)
Figure Global Hereditary Angioedema Treatment Sales Market Share by Application in 2019
Figure Global Hospital Pharmacies Sales Growth Rate (2015-2020)
Figure Global Retail Pharmacies Sales Growth Rate (2015-2020)
Figure Global Others (online pharmacies, mail pharmacies) Sales Growth Rate (2015-2020)
Figure Global Hereditary Angioedema Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Global Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Global Hereditary Angioedema Treatment Price and Trend Forecast (2020-2025)
Table Global Hereditary Angioedema Treatment Sales (K Units) Forecast by Region (2020-2025)
Figure Global Hereditary Angioedema Treatment Production Market Share Forecast by Region (2020-2025)
Figure North America Hereditary Angioedema Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Hereditary Angioedema Treatment Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Hereditary Angioedema Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Hereditary Angioedema Treatment Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Hereditary Angioedema Treatment Revenue (Million US$) Growth Rate Forecast (2020-2025)
Table CSL Company Profile
Figure Hereditary Angioedema Treatment Product Picture and Specifications of CSL
Table Hereditary Angioedema Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure CSL Hereditary Angioedema Treatment Market Share (2018-2020)
Table CSL Main Business
Table CSL Recent Development
Table Ionis Pharmaceuticals Company Profile
Figure Hereditary Angioedema Treatment Product Picture and Specifications of Ionis Pharmaceuticals
Table Hereditary Angioedema Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Ionis Pharmaceuticals Hereditary Angioedema Treatment Market Share (2018-2020)
Table Ionis Pharmaceuticals Main Business
Table Ionis Pharmaceuticals Recent Development
Table Pharming Group Company Profile
Figure Hereditary Angioedema Treatment Product Picture and Specifications of Pharming Group
Table Hereditary Angioedema Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Pharming Group Hereditary Angioedema Treatment Market Share (2018-2020)
Table Pharming Group Main Business
Table Pharming Group Recent Development
Table KalVista Pharmaceuticals Company Profile
Figure Hereditary Angioedema Treatment Product Picture and Specifications of KalVista Pharmaceuticals
Table Hereditary Angioedema Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure KalVista Pharmaceuticals Hereditary Angioedema Treatment Market Share (2018-2020)
Table KalVista Pharmaceuticals Main Business
Table KalVista Pharmaceuticals Recent Development
Table Shire plc (Takeda Pharmaceutical Company Limited) Company Profile
Figure Hereditary Angioedema Treatment Product Picture and Specifications of Shire plc (Takeda Pharmaceutical Company Limited)
Table Hereditary Angioedema Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Shire plc (Takeda Pharmaceutical Company Limited) Hereditary Angioedema Treatment Market Share (2018-2020)
Table Shire plc (Takeda Pharmaceutical Company Limited) Main Business
Table Shire plc (Takeda Pharmaceutical Company Limited) Recent Development
Table BioCryst Pharmaceuticals Company Profile
Figure Hereditary Angioedema Treatment Product Picture and Specifications of BioCryst Pharmaceuticals
Table Hereditary Angioedema Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure BioCryst Pharmaceuticals Hereditary Angioedema Treatment Market Share (2018-2020)
Table BioCryst Pharmaceuticals Main Business
Table BioCryst Pharmaceuticals Recent Development
Table Attune Pharmaceuticals Company Profile
Figure Hereditary Angioedema Treatment Product Picture and Specifications of Attune Pharmaceuticals
Table Hereditary Angioedema Treatment Production, Price, Revenue and Gross Margin of 2018-2020
Figure Attune Pharmaceuticals Hereditary Angioedema Treatment Market Share (2018-2020)
Table Attune Pharmaceuticals Main Business
Table Attune Pharmaceuticals Recent Development
Table of Appendix